Latest From Guerbet SA
US FDA is requiring additional safety measures related to GBCAs, but holds that there is no direct relationship established between gadolinium retention and kidney function.
Advisory committee agrees that risks of gadolinium retention in the brain and other organs need further study; actor Chuck Norris' wife was among several patients who testified of devastating medical problems following administration of agents.
US FDA advisory committee to consider whether regulatory actions such as a labeling change are needed and what studies could be done to investigate potential adverse events associated with gadolinium retention in the brain and other body organs.
Medical imaging specialist Guerbet has appointed a new chief digital officer to oversee the company's innovation strategy.
Diagnostic Imaging Equipment & Supplies
- MRI, NMR
- Diagnostic Imaging Equipment & Supplies
- Radiopharmaceuticals, Contrast Agents
- Therapeutic Areas
- Western Europe
- Parent & Subsidiaries
- Guerbet SA
- Senior Management
Yves L'Epine, CEO
Jean-Francois Le Martret, CFO
- Contact Info
Phone: (33) 1 45 91 50 00
Rue des Vanesses, 15
P.O. Box 50400 Villepinte, 93420
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.